Illumina (ILMN)

A trailblazer in genomics, Illumina drives progress in DNA sequencing and precision medicine. Its platforms underpin much of the biotech sectors research, offering scalable tools that fuel personalized healthcare, population genomics, and next-gen diagnostics with the potential to redefine how humanity understands itself.

Year Invested

2023

Industry

Biotechnology

Status

Active